Histogen Inc (HSTO) |
|
1.17 0 (0%)
|
03-03 16:20 |
|
Open: |
1.19 |
Pre. Close: |
1.17 |
|
High:
|
1.25 |
Low:
|
1.11 |
|
Volume:
|
2,661,337 |
Market Cap:
|
31M |
|
|
|
|
Histogen Inc., a regenerative medicine company, develops therapies based upon the products of cells grown under simulated embryonic conditions. It offers human multipotent cell conditioned media (CCM); human extracellular matrix (hECM); and hair stimulating complex (HSC). The company's technology focuses on stimulating a patient's own stem cells by delivering a complex of multipotent human proteins that support stem cell growth and differentiation. Histogen Inc. is headquartered San Diego, California. |
Stock Price Prediction |
Update at 5:00pm EST |
|
If tomorrow:
|
Open lower
|
Open higher
|
|
High:
|
1.212 - 1.217 |
1.217 - 1.223 |
|
Low:
|
1.133 - 1.14 |
1.14 - 1.147 |
|
Close:
|
1.157 - 1.168 |
1.168 - 1.179 |
|
Technical analysis |
as of: 2021-03-03 4:05:08 PM |
|
Overall:
|
  |
| Stoxline posted a NEUTRAL today, upgraded from lower rating. Current trend continues, but could change at anytime. It is not a good time to buy or sell. |
| Target: |
Six months: 1.91 One year: 2.31 |
| Support: |
Support1: 1.08 Support2: 0.90 |
| Resistance: |
Resistance1: 1.64 Resistance2: 1.98 |
| Pivot: |
1.42  |
| Moving Average: |
MA(5): 1.17 MA(20): 1.42
MA(100): 1.42 MA(250): 2.50 |
| MACD: |
MACD(12,26): -0.03 Signal(9): 0.03 |
| Stochastic oscillator: |
%K(14,3): 8.24 %D(3): 7.92 |
| RSI: |
RSI(14): 42.07 |
| 52-week: |
High: 7.50 Low: 0.75 Change(%): -72.9 |
| Average Vol(K): |
3-Month: 383081 10-Days: 705327 |
|
Price, moving averages and Bollinger Bands |
|
Price and moving averages has closed below its Short term moving average. Short term moving average is currently above mid-term; AND below long term moving averages. From the relationship between price and moving averages; we can see that: This stock is NEUTRAL in short-term; and NEUTRAL in mid-long term.HSTO has closed above bottom band by 19.7%. Bollinger Bands are 59.7% wider than normal. The large width of the bands suggest high volatility as compared to HSTO's normal range. The bands have been in this wide range for 3 bars. This is a sign that the current trend might continue. |
|
|
Headline News |
Tue, 02 Mar 2021
Histogen to Present at the H.C. Wainwright Global Life Sciences Virtual Conference - Yahoo Finance
Wed, 24 Feb 2021
Premarket Mover: Histogen Inc (HSTO) Up 7.50% - InvestorsObserver
Tue, 16 Feb 2021
Histogen Announces Week 26 HST-001 Study Results for the Treatment of Androgenic Alopecia in Men - Yahoo Finance
Tue, 16 Feb 2021
Histogen Inc (HSTO) Stock: Is It a Good Pick? - InvestorsObserver
Tue, 16 Feb 2021
Histogen Inc. (HSTO) Announces Week 26 HST-001 Study Results for the Treatment of Androgenic Alopecia in Men - StreetInsider.com
Wed, 10 Feb 2021
Premarket Mover: Histogen Inc (HSTO) Up 9.52% - InvestorsObserver
|
Financial Analysis |
| Growth |
NA |
| Growth measures the growth of both a company's revenue and net income. it tells investors how fast a company is growing. |
| Profitability |
NA |
| Profitability measures a company’s ability to generate earnings as compared to its expenses and other relevant costs. |
| Solvency |
NA |
| Solvency measures a company's ability to meet its long-term debts. Acceptable solvency ratios will vary from industry to industry. |
| Efficiency |
NA |
| Efficiency measures the strength of a company's return on invested capital. It can identify business that are better managed or not. |
| Price to Book Value: |
Outperform |
Discounted cash flow: |
Outperform |
| Return on Assets: |
Underperform |
Price to Earnings: |
Underperform |
| Return on Equity: |
Underperform |
Debt to Equity: |
Outperform |
|
|
|
|
|
|
| Free Technical Analysis Charts
|
|
|
Stock Basics & Statistics |
| Exchange: NASDAQ |
| Sector: Healthcare |
| Industry: Biotechnology |
| Shares Out. (M) |
27 |
| Shares Float (M) |
10 |
|
% Held by Insiders
|
31.98 |
|
% Held by Institutions
|
3.90 |
|
Shares Short (K)
|
95 |
|
Shares Short P. Month (K)
|
75 |
Stock Financials |
|
EPS
|
|
|
EPS Est This Year
|
|
|
EPS Est Next Year
|
|
|
Book Value (p.s.)
|
|
|
Profit Margin
|
|
|
Operating Margin
|
-413.24 |
|
Return on Assets (ttm)
|
-82.1 |
|
Return on Equity (ttm)
|
-338.5 |
|
Qtrly Rev. Growth
|
57.6 |
|
Gross Profit (p.s.)
|
0.115 |
|
Sales Per Share
|
0.118 |
|
EBITDA (p.s.)
|
-0.483 |
|
Qtrly Earnings Growth
|
|
|
Operating Cash Flow (M)
|
-10 |
|
Levered Free Cash Flow (M)
|
-8 |
Stock Valuations |
|
PE Ratio
|
|
|
PEG Ratio
|
|
|
Price to Book value
|
|
|
Price to Sales
|
9.67 |
|
Price to Cash Flow
|
-3.14 |
Stock Dividends |
|
Dividend
|
|
|
Forward Dividend
|
|
|
Dividend Yield
|
|
|
Dividend Pay Date
|
Invalid DateTime. |
|
Ex-Dividend Date
|
Invalid DateTime. |
|
7 Binary Options
|
|
Your Ad Here
|
|
